Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04284371 · ClinicalTrials.gov registry record

The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients

A clinical trial, sponsored by The Geneva Foundation.

Terminated
Registry status
150
Enrollment target

NCT04284371: Clinical Trial study, sponsored by The Geneva Foundation.

NCT04284371 is a clinical trial that was terminated before completion, run by The Geneva Foundation. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04284371 was terminated before completion, sponsored by The Geneva Foundation.

TERMINATED
Registry status
150 participants
Enrollment target

Study Summary

The prevalence of liver steatosis, steatohepatitis, fibrosis, and hemosiderosis in overweight and obese US Military dependent pediatric patients using MR Elastography and Quantitative MRI

Primary Outcome

LMS Imagery will be used to for observance of the prevalence of liver fibrosis, steatosis, steatohepatitis and hemosiderosis on LMS in overweight and obese US Military dependents between ages 10 and 17

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2016-02-10
Est. Completion 2021-01-26
The Geneva Foundation

11 total trials

Why NCT04284371 stopped before completion

NCT04284371 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT04284371 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04284371 about?

NCT04284371 is a clinical study titled "The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients". The prevalence of liver steatosis, steatohepatitis, fibrosis, and hemosiderosis in overweight and obese US Military dependent pediatric patients using MR Elastography and Quantitative MRI

What is the current status of trial NCT04284371?

This trial is currently terminated. The enrollment target is 150 participants. The study started on 2016-02-10. Estimated completion is 2021-01-26.

Who is sponsoring clinical trial NCT04284371?

This trial is sponsored by The Geneva Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04284371, the US trial registry maintained by the National Library of Medicine. NCT04284371 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.